Improving opioid prescription practices and reducing patient risk in the primary care setting

Journal of Pain Research

Volumn 7, Issue , 2014, Pages 301-311

  Cheatle, Martin D ^a   Barker, Cody ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Addiction; Chronic pain; Opioids

Indexed keywords

OPIATE;

ANALGESIA; CHRONIC NONCANCER PAIN; CHRONIC PAIN; CLINICAL ASSESSMENT TOOL; COGNITIVE THERAPY; COMPUTER ASSISTED THERAPY; CONSTIPATION; DEPRESSION; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG MISUSE; DRUG MONITORING; FALL RISK; FRACTURE RISK; HUMAN; HYPERALGESIA; HYPOGONADISM; IMMUNE DEFICIENCY; INTERVIEW; MENTAL HEALTH SCREENING; MOBILE APPLICATION; NAUSEA; PATIENT CARE; PATIENT MONITORING; PATIENT RISK; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; REVIEW; RISK; RISK ASSESSMENT; RISK REDUCTION; SCREENING; SEDATION; SLEEP DISORDER; SLEEP DISORDER SCREENING; SUBSTANCE ABUSE; TELEHEALTH; TELEMEDICINE; URINE DRUG MONITORING;

EID: 84902306604     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S37306     Document Type: Review

References (108)

1. Magni G, Marchetti M, Moreschi C, Merskey H, Luchini S. Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination, I: epidemiologic follow-up study. Pain. 1993;53(2):163-168.
2. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20): 2433-2445.
3. Miller LR, Cano A. Comorbid chronic pain and depression: who is at risk? J Pain. 2009;10(6):619-627.
4. McWilliams LA, Cox BJ, Enns M W. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003;106(1/2):127-133.
5. Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8(7):573-582.
6. Turk DC, Paice JA, Cowan P, et al. American Pain Society. Interdisciplinary pain management. Available from: http://www.americanpainsociety.org/uploads/pdfs/2010InterdisciplinaryWhitePaper-FINAL.pdf. Accessed March 1, 2014.
7. Schatman ME. Interdisciplinary chronic pain management: international perspectives. ISAP Pain Clinical Updates. 2012;20(7): 1-5.
8. Tsang A, Von Korff M, Lee S, et al. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain. 2008;9(10): 883-891.
9. Upshur CC, Luckmann RS, Savageau JA. Primary care provider concerns about management of chronic pain in community clinic populations. J Gen Intern Med. 2006;21(6):652-655.
10. Furlan AD, Chaparro LE, Irvin E, Mailis-Gagnon A. A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain. Pain Res Manage. 2011;16(5):337-351.
11. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;1:CD006605.
12. Chaparro LE, Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S, Turk DC. Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev. 2013;8:CD004959.
13. Brown RT, Zuelsdorff M, Fleming M. Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain. J Opioid Manag. 2006;2(3):137-146.
14. Cheatle MD, Savage SR. Informed consent in opioid therapy: a potential obligation and opportunity. J Pain Symptom Manage. 2012;44(1):105-116.
15. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-46, HHS Publication No (SMA) 13-4795. Rockville, MD, USA: Substance Abuse and Mental Health Services Administration; 2013. Available from: http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.pdf. Accessed May 2, 2014.
16. Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011. National Estimates of Drug-Related Emergency Department Visits. HHS Publication No (SMA) 13-4760, DAWN Series D-39. Rockville, MD, USA: Substance Abuse and Mental Health Services Administration; 2013. Available from: http://www.samhsa.gov/data/2k13/DAWN2k11ED/DAWN2k11ED.htm. Accessed May 2, 2014.
17. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2001-2011. National Admissions to Substance Abuse Treatment Services. BHSIS Series S-65, HHS Publication No (SMA) 13-4772. Rockville, MD, USA: Substance Abuse and Mental Health Services Administration; 2013. Available from: http://www.samhsa.gov/data/2k13/TEDS2011/TEDS2011N.pdf. Accessed May 2, 2014.
18. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17(3):173-179.
19. Katz N, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97(4):1097-1102.
20. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:46.
21. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, effcacy, and association with addiction. Ann Intern Med. 2007;146(2):116-127.
22. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008;9(4):444-459.
23. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309(7):657-659.
24. Nuckols TK, Anderson L, Popescu I, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2014;160(1):38-47.
25. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
26. National Opioid Use Guideline Group Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. Hamilton, ON, Canada: McMaster University; 2010. Available from: http://nationalpaincentre.mcmaster.ca/opioid/cgop_a00_executive_summary.html. Accessed November 18, 2013.
27. Tracey I, Bushnell MC. How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J Pain. 2009;10(11):1113-1120.
28. Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC, USA: The National Academies Press; 2011.
29. Breuer B, Cruciani R, Portenoy RK. Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: a national survey. South Med J. 2010;103(8):738-747.
30. Wagner EH, Austin BT, Von Korff M. Improving outcomes in chronic illness. Manag Care Q. 1996;4(2):12-25.
31. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2-4.
32. Heapy A, Kerns RD. Psychological and behavioral assessment. In: Benzon HT, Rathmel J P, Wu CL, Turk DC, Argoff CE, editors. Raj's Practical Management of Pain. 4 th ed. Philadelphia, PA, USA: Mosby/ Elsevier; 2008.
33. Morgan L, Weaver M, Sayeed Z, Orr R. The use of prescription monitoring programs to reduce opioid diversion and improve patient safety. J Pain Palliat Care Pharmacother. 2013;27(1):4-9.
34. Cheatle MD, O'Brien C P. Opioid therapy in patients with chronic non-cancer pain: diagnostic and clinical challenges. Adv Psychosom Med. 2011;30:61-91.
35. Lalani I, Argoff CE. History and physical examination of the pain patient. In: Benzon HT, Rathmel J P, Wu CL, Turk DC, Argoff CE, editors. Raj's Practical Management of Pain. 4th ed. Philadelphia, PA, USA: Mosby/Elsevier; 2008.
36. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain. 2008;24(6):497-508.
37. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6:432-442.
38. Butler S, Budman S, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112(1/2):65-75.
39. Belgrade M, Schamber C, Lindgren B. The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain. 2006;7(9):671-681.
40. Skinner HA. The drug abuse screening test. Addict Behav. 1982;7(4): 363-371.
41. Passik S, Kirsh KL, Whitcomb L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26(4):552-561.
42. Butler S, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain. 2007;130(1/2):144-156.
43. Becker WC, Fraenkel L, Edelman EJ, Holt SR, Glover J, Kerns RD, Fiellin DA. Instruments to assess patient-reported safety, effcacy, or misuse of current opioid therapy for chronic pain: a systematic review. Pain. 2013;154(6):905-916.
44. Peppin JF, Passik SD, Couto JE, et al. Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain. Pain Med. 2012;134(7):886-896.
45. Bhamb B, Brown D, Hariharan J, et al. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin. 2006;22(9):1859-1865.
46. Boulanger A, Clark AJ, Squire P, Cui E, Horbay GL. Chronic pain in Canada: have we improved our management of chronic noncancer pain? Pain Res Manag. 2007;12(1):39-47.
47. Reisfeld GM, Graham NA, Gold MS. Urine drug testing is still an invaluable resource for primary care. Ann Intern Med. 2010;153(6):420.
48. Gourlay D, Heit H, Caplan Y. Urine drug testing in clinical practice: the art and science of patient care. 5th ed. Available from: http://www.pharmacomgroup.com/udt/udt5.pdf. Accessed December 1, 2013.
49. Cheatle MD. Depression, chronic pain, and suicide by overdose: on the edge. Pain Med. 2011;12 Suppl 2:S43-S48.
50. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
51. McNair D, Lorr M, Droppleman L. Profle of Mood States. San Diego, CA, USA: Educational and Industrial Testing Service; 1971.
52. Dworkin R, Turk DC, Farrar JT, et al. IMMPACT. Core outcome measures for chronic pain trials: IMMPACT recommendations. Pain. 2005;113(1/2):9-19.
53. Beck A, Steer R, Brown C. Beck Depression Inventory-Fast Screen for Medical Patients Manual. San Antonio, TX, USA: Psychological Corporation; 2000.
54. Zung W. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63-70.
55. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
56. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
57. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1 000 study. JAMA. 1994;272(22):1749-1756.
58. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic metaanalysis. J Gen Intern Med. 2007;22(11):1596-1602.
59. Lowe B, Grafe K, Zipfel S, et al. Diagnosing ICD-10 depressive episodes: superior criterion validity of the patient health questionnaire. Psychother Psychosom. 2004;73(6):386-390.
60. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893-897.
61. Spielberg C, Gorsuch R, Lushene R. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA, USA: Consulting Psychologists; 1970.
62. Bjelland L, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69-77.
63. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1-15.
64. Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultrabrief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613-621.
65. Atkinson JH, Ancoli-Israel S, Slater M, et al. Subjective sleep disturbance in chronic pain. Clin J Pain. 1988;4:225-232.
66. Morin C, Gibson D, Wade J. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain. 1998;14:311-314.
67. Allen KD, Renner JB, DeVellis B, Helmick C, Jordan JM. Osteoarthritis and sleep: the Johnston County Osteoarthritis Project. J Rheumatol. 2008;35(6):1102-1107.
68. Moldofsky H. Sleep and pain. Sleep Med Rev. 2001;5(5):385-396.
69. Smith MT, Haythornthwaite JA. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev. 2004;8(2):119-132.
70. Brennan MJ, Lieberman JA. Sleep disturbances in patients with chronic pain: effectively managing opioid analgesia to improve outcomes. Curr Med Res Opin. 2009;25(5):1045-1055.
71. Shaw IR, Lavigne G, Mayer P, Choiniere M. Acute intravenous administration of morphine perturbs sleep architecture in healthy pain-free young adults: a preliminary study. Sleep. 2005;28(6):677-682.
72. Rosenberg J. Sleep disturbances after non-cardiac surgery. Sleep Med Rev. 2001;5(2):129-137.
73. Webster LR, Choi Y, Desai H, Webster L, Grant BJ. Sleep-disordered breathing and chronic opioid therapy. Pain Med. 2008;9(4): 425-432.
74. Walker JM, Farney RJ. Are opioids associated with sleep apnea? A review of the evidence. Curr Pain Headache Rep. 2009;13(2):120-126.
75. Mogri M, Desai H, Webster L, Grant BJ, Mador MJ. Hypoxemia in patients on chronic opiate therapy with and without sleep apnea. Sleep Breath. 2009;13(1):49-57.
76. Moul DE, Hall M, Pilkonis PA, Buysse DJ. Self-report measures of insomnia in adults: rationales, choices, and needs. Sleep Med Rev. 2004;8(3):177-198.
77. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213.
78. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107-112.
79. Kroenke K, Bair MJ, Damush TM, et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA. 2009;301(20):2099-2110.
80. Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark H W. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 2009;99(1-3): 280-295.
81. US Department of Health and Human Services, Health Resources and Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. Available from: http://www.hrsa.gov/ruralhealth/about/telehealth/. Accessed January 14, 2014.
82. Liss HJ, Glueckauf RJ, Ecklund-Johnson E P. Research on telehealth and chronic medical conditions: critical review, key issues, and future directions. Rehabil Psychol. 2002;47(1):8-30.
83. Cuijpers P, Marks IM, van Straten A, Cavanagh K, Gega L, Andersson G. Computer-aided psychotherapy for anxiety disorders: a meta-analytic review. Cogn Behav Ther. 2009;38(2):66-82.
84. Keogh E, Rosser BA, Eccleston C. e-health and chronic pain management: current status and developments. Pain. 2010;151(1):18-21.
85. Sato AF, Clifford LM, Silverman AH, Davies W. Cognitive-behavioral interventions via telehealth: applications to pediatric functional abdominal pain. Child Health Care. 2009;38(1):1-22.
86. Tuerk P W, Yoder M, Ruggiero K, Gros DF, Acierno R. A pilot study of prolonged exposure therapy for posttraumatic stress disorder delivered via telehealth technology. J Trauma Stress. 2010;23(1):116-123.
87. Manchikanti L. CBT for low-back pain in primary care. Lancet. 2010;375(9718):869-870.
88. Lamb SE, Hansen Z, Lall R, Castelnuovo E, Withers EJ, Nichols V. Group cognitive behavioural treatment for low-back pain in primary care: a randomized controlled trial and cost-effectiveness analysis. Lancet. 2010;375(9718):916-923.
89. Thieme K, Flor H, Turk D. Psychological pain treatment in fbromyalgia syndrome: effcacy of operant behavioral and cognitive behavioral treatments. Arthritis Res Ther. 2006;8(4):R121.
90. Linton SJ. A 5-year follow-up evaluation of the health and economic consequences of an early cognitive behavioral intervention for back pain: a randomized, controlled trial. Spine. 2006;31(8):853-858.
91. Keefe FJ, Caldwell DS. Cognitive behavioral control of arthritis pain. Med Clin North Am. 1997;81(1):277-290.
92. Chen E, Cole S W, Kato PM. A review of empirically supported psychosocial interventions for pain and adherence outcomes in sickle cell disease. J Pediatr Psychol. 2004;29(3):1997-2009.
93. Glombiewski JA, Hartwich-Tersek J, Rief W. Two psychological interventions are effective in severely disabled, chronic back pain patients: a randomized controlled trial. Int J Behav Med. 2010;17(2):97-107.
94. Turner JA, Manci L, Aaron LA. Short-and long-term efficacy of brief cognitive-behavioral therapy for patients with chronic temporomandibular disorder pain: a randomized, controlled trial. Pain. 2006;121(3):181-194.
95. Greco CM, Rudy TE, Manzi S. Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: a randomized controlled trial. Arthritis Rheum. 2004;51(4):625-634.
96. Holder HD, Cisler R, Longabaugh R, Stout RL, Treno AJ, Zweben A. Alcoholism treatment and medical care costs from Project MATCH. Addiction. 2000;95(7):999-1013.
97. Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto M W. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2):179-187.
98. Osilla KC, Hepner KA, Muñoz R F, Woo S, Watkins K. Developing an integrated treatment for substance use and depression using cognitive-behavioral therapy. J Subst Abuse Treat. 2009;37(4):412-420.
99. Kay-Lambkin FJ, Baker AL, Lewin T, Carr VJ. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical effcacy. Addiction. 2009;104(3):378-388.
100. Dear B F, Titov N, Perry KN, et al. The Pain Course: a randomised controlled trial of a clinician-guided Internet-delivered cognitive behaviour therapy program for managing chronic pain and emotional well-being. Pain. 2013;154(6):942-950.
101. Riper H, Spek V, Boon B, et al. Effectiveness of E-self-help interventions for curbing adult problem drinking: a meta-analysis. J Med Internet Res. 2011;13(2):e42.
102. Dulin PL, Gonzalez VM, King DK, Giroux D, Bacon S. Smartphone-based, self-administered intervention system for alcohol use disorders: theory and empirical evidence basis. Alcohol Treat Q. 2013;31(3).
103. Kristjánsdóttir OB, Fors EA, Eide E, et al. A smartphone-based intervention with diaries and therapist-feedback to reduce catastrophizing and increase functioning in women with chronic widespread pain: randomized controlled trial. J Med Internet Res. 2013;15(1):e72.
104. Wallace LS, Dhingra LK. A systematic review of smartphone applications for chronic pain available for download in the United States. J Opioid Manag. 2014;10(1):63-68.
105. Kroenke K, Krebs E, Wu J, et al. Stepped Care to Optimize Pain care Effectiveness (SCOPE) trial study design and sample characteristics. Contemp Clin Trials. 2013;34(2):270-281.
106. Cahana A, Dansie EJ, Theodore BR, Wilson HD, Turk DC. Redesigning delivery of opioids to optimize pain management, improve outcomes, and contain costs. Pain Med. 2013;14(1):36-42.
107. Patient Protection and Affordable Care Act. Public Law No: 1 11-148: HR 3590. March 23, 2010.
108. Trafton JA, Martins SB, Michel MC, et al. Designing an automated clinical decision support system to match clinical practice guidelines for opioid therapy for chronic pain. Implement Sci. 2010;5:26.